Suppr超能文献

接受持续性非卧床腹膜透析和血液透析患者的血脂参数,包括脂蛋白(a) 。

Lipid parameters including lipoprotein (a) in patients undergoing CAPD and hemodialysis.

作者信息

Siamopoulos K C, Elisaf M S, Bairaktari H T, Pappas M B, Sferopoulos G D, Nikolakakis N G

机构信息

Department of Internal Medicine, University of Ioannina, Greece.

出版信息

Perit Dial Int. 1995 Oct-Dec;15(8):342-7.

PMID:8785232
Abstract

OBJECTIVE

Dyslipidemia possibly contributes to the vascular complications commonly afflicting uremic patients. Lipoprotein (a) [Lp(a)] has been identified as an independent risk factor for atherosclerotic vascular disease. The aim of our study was to compare lipidparameters, including Lp(a), between hemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD) patients.

DESIGN

A cross-sectional study.

SETTING

University Medical Center.

PARTICIPANTS

Forty CAPD and 40 HD patients carefully matched for age, sex, body mass index (BMI), smoking habits, and duration of dialysis were studied. A group of 40 healthy individuals matched for age, sex, BMI, and smoking habits was used as control.

INTERVENTIONS

None.

MAIN OUTCOME MEASURES

Serum lipid parameters and atherogenic risk ratios were the main outcome measures.

RESULTS

Both groups of dialysis patients had increased serum triglycerides and decreased levels of ApoA1 and HDL cholesterol compared to controls. Moreover, the risk ratios total cholesterol/HDL cholesterol and LDL cholesterol/HDL cholesterol were significantly higher, and the ratio ApoA1/ApoB was significantly lower in both groups of patients in comparison to the normal subjects. Both groups of dialysis patients exhibited decreased ratios of LDL cholesterol/ApoB and HDL cholesterol/ApoA1, suggesting the presence of compositional lipoprotein changes. CAPD patients had a more atherogenic lipid profile compared to HD patients, since they exhibited higher levels of total and LDL cholesterol, of ApoB as well as of the ratios total cholesterol/HDL cholesterol and LDL cholesterol/HDL cholesterol, and lower levels of the ratio ApoA1/ApoB compared to HD patients. Both groups of dialysis patients had increased serum Lp(a) levels. Even though CAPD patients had higher serum Lp(a) levels than HD patients, the differences between these two groups were only marginally statistically significant (p = 0.056 by Mann-Whitney U-test). Uremic dyslipidemia was positively correlated with serum albumin levels in both groups of patients.

CONCLUSION

CAPD patients exhibit a more atherogenic lipid profile than that of HD patients. The marked disturbances in Lp(a) levels may further increase the vascular risk in both groups of patients.

摘要

目的

血脂异常可能导致尿毒症患者常见的血管并发症。脂蛋白(a)[Lp(a)]已被确定为动脉粥样硬化性血管疾病的独立危险因素。我们研究的目的是比较血液透析(HD)和持续性非卧床腹膜透析(CAPD)患者之间的血脂参数,包括Lp(a)。

设计

横断面研究。

地点

大学医学中心。

参与者

研究了40例CAPD患者和40例HD患者,这些患者在年龄、性别、体重指数(BMI)、吸烟习惯和透析时间方面进行了仔细匹配。一组40名年龄、性别、BMI和吸烟习惯相匹配的健康个体作为对照。

干预措施

无。

主要观察指标

血清脂质参数和动脉粥样硬化风险比是主要观察指标。

结果

与对照组相比,两组透析患者血清甘油三酯均升高,载脂蛋白A1和高密度脂蛋白胆固醇水平均降低。此外,两组患者的总胆固醇/高密度脂蛋白胆固醇和低密度脂蛋白胆固醇/高密度脂蛋白胆固醇风险比显著更高,而载脂蛋白A1/载脂蛋白B比值显著低于正常受试者。两组透析患者的低密度脂蛋白胆固醇/载脂蛋白B和高密度脂蛋白胆固醇/载脂蛋白A1比值均降低,提示存在脂蛋白组成变化。与HD患者相比,CAPD患者的脂质谱更具动脉粥样硬化性,因为他们的总胆固醇和低密度脂蛋白胆固醇、载脂蛋白B水平以及总胆固醇/高密度脂蛋白胆固醇和低密度脂蛋白胆固醇/高密度脂蛋白胆固醇比值更高,而载脂蛋白A1/载脂蛋白B比值低于HD患者。两组透析患者的血清Lp(a)水平均升高。尽管CAPD患者的血清Lp(a)水平高于HD患者,但两组之间的差异仅具有微弱的统计学意义(Mann-Whitney U检验,p = 0.056)。两组患者的尿毒症血脂异常均与血清白蛋白水平呈正相关。

结论

CAPD患者的脂质谱比HD患者更具动脉粥样硬化性。Lp(a)水平的明显紊乱可能会进一步增加两组患者的血管风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验